Interleukin-18 mediated inflammatory brain injury after intracerebral hemorrhage in male mice

J Neurosci Res. 2022 Jun;100(6):1359-1369. doi: 10.1002/jnr.25044. Epub 2022 Mar 22.

Abstract

Interleukin-18 (IL-18), a pro-inflammatory cytokine, is thought to be associated with inflammation in many neurological diseases such as ischemic stroke and poststroke depression, but the role of IL-18 in inflammatory injury after intracerebral hemorrhage (ICH) remains unclear. In this study, we established the ICH model in male mice and found that IL-18 expression including protein and mRNA levels was significantly increased in brain tissues after ICH. Meanwhile, exogenous IL-18 exacerbated cerebral hematoma and neurological deficits following ICH. In the IL-18 knockout group, the size of hematoma and neurological functions after ICH was decreased compared with the wild-type group, suggesting the critical role of IL-18 on the modulation of brain injury after ICH. Importantly, exogenous IL-18 increased microglial activation in brain tissues after ICH. Furthermore, IL-18 knockout resulted in the reduction of activated microglia after ICH. These results indicated that IL-18 may regulate the inflammatory response after ICH through the activation of microglia. Thus, IL-18 is expected to be a promising therapeutic target for secondary brain injury after ICH.

Keywords: RRID:AB-2099233; RRID:AB-2715541; RRID:AB-2895063; RRID:AB-2895090; RRID:AB-330924; RRID:AB_2535792; RRID:AB_839504; RRID:IMSR-NM-KO-190469; RRID:MGI:5657312; RRID:SCR_000306; RRID:SCR_001964; RRID:SCR_003070; behavior; brain injury; interleukin-18; intracerebral hemorrhage; microglia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain Injuries* / complications
  • Brain Injuries* / metabolism
  • Cerebral Hemorrhage / drug therapy
  • Hematoma / complications
  • Hematoma / metabolism
  • Interleukin-18*
  • Male
  • Mice
  • Microglia / metabolism

Substances

  • Interleukin-18